DE3683482D1 - Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression. - Google Patents

Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.

Info

Publication number
DE3683482D1
DE3683482D1 DE8686902986T DE3683482T DE3683482D1 DE 3683482 D1 DE3683482 D1 DE 3683482D1 DE 8686902986 T DE8686902986 T DE 8686902986T DE 3683482 T DE3683482 T DE 3683482T DE 3683482 D1 DE3683482 D1 DE 3683482D1
Authority
DE
Germany
Prior art keywords
expression
cdns
genes
angiogenesis factor
human angiogenin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686902986T
Other languages
English (en)
Inventor
L Vallee
Kotoku Kurachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Application granted granted Critical
Publication of DE3683482D1 publication Critical patent/DE3683482D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8686902986T 1985-08-28 1986-04-16 Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression. Expired - Lifetime DE3683482D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77065785A 1985-08-28 1985-08-28
US06/778,547 US4721672A (en) 1985-08-28 1985-09-20 CDNA and gene for human angiogenin (angiogenesis factor) and methods of expression
PCT/US1986/000809 WO1987001372A1 (en) 1985-08-28 1986-04-16 cDNA AND GENE FOR HUMAN ANGIOGENIN (ANGIOGENESIS FACTOR) AND METHODS OF EXPRESSION

Publications (1)

Publication Number Publication Date
DE3683482D1 true DE3683482D1 (de) 1992-02-27

Family

ID=27118341

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686902986T Expired - Lifetime DE3683482D1 (de) 1985-08-28 1986-04-16 Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.

Country Status (8)

Country Link
US (2) US4721672A (de)
EP (1) EP0235162B1 (de)
JP (2) JPH0638749B2 (de)
AT (1) ATE71632T1 (de)
CA (1) CA1316132C (de)
DE (1) DE3683482D1 (de)
DK (1) DK215287A (de)
WO (1) WO1987001372A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721672A (en) * 1985-08-28 1988-01-26 President And Fellows Of Harvard College CDNA and gene for human angiogenin (angiogenesis factor) and methods of expression
US4966849A (en) * 1985-09-20 1990-10-30 President And Fellows Of Harvard College CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression
FR2610324A1 (fr) * 1987-01-29 1988-08-05 Genetica Sa Preparation par voie microbiologique de l'angiogenine humaine et conversion de l'enzyme ainsi obtenue en sa forme active
US4808402A (en) * 1987-05-29 1989-02-28 Northwestern University Method and compositions for modulating neovascularization
US5008196A (en) * 1987-08-21 1991-04-16 Monsanto Company Stimulation of endothelial cell growth
FR2623509B1 (fr) * 1987-11-19 1990-04-20 Centre Nat Rech Scient Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments
US4900673A (en) * 1988-03-28 1990-02-13 President And Fellows Of Harvard College Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression
WO1989012645A1 (en) * 1988-06-22 1989-12-28 Synergen, Inc. Angiogenic potentiating peptides which potentiate angiogenic factors
US6899882B1 (en) 1989-03-24 2005-05-31 The Regents Of The University Of California Endothelial cell growth factor methods of isolation and expression
US7300791B2 (en) * 1989-05-12 2007-11-27 Genentech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US20030114374A1 (en) * 1989-05-12 2003-06-19 Genentech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
IL96519A0 (en) * 1990-02-15 1991-08-16 Harvard College Covalent angiogenin/rnase hybrids
US5270204A (en) * 1990-02-15 1993-12-14 The President And Fellows Of Harvard College Covalent angiogenin/RNase hybrids
EP0648264A4 (de) * 1992-06-03 1997-10-01 Univ Case Western Reserve Permanenter verband zur verabreichung von biologischen produkten.
AU673865B2 (en) * 1992-10-29 1996-11-28 Australian National University, The Angiogenesis inhibitory antibodies
US6321109B2 (en) 1996-02-15 2001-11-20 Biosense, Inc. Catheter based surgery
US6443974B1 (en) 1996-07-28 2002-09-03 Biosense, Inc. Electromagnetic cardiac biostimulation
US5852001A (en) * 1996-12-23 1998-12-22 The Endowment For Research In Human Biology Method and compounds for inhibition of ribonucleases
AU6578298A (en) 1997-03-21 1998-10-20 President And Fellows Of Harvard College Antisense inhibition of angiogenin expression
EP1563866B1 (de) 1998-02-05 2007-10-03 Biosense Webster, Inc. Gerät zum Freisetzen eines Medikaments im Herzen
US20030113303A1 (en) * 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
US20030129750A1 (en) * 1998-02-05 2003-07-10 Yitzhack Schwartz Homing of donor cells to a target zone in tissue using active therapeutics or substances
EP1545608A4 (de) 2002-06-28 2006-09-13 Centocor Inc Ch1-deletierte säugetier-mimetikörper, zusammensetzungen, verfahren und anwendungen
GB0425625D0 (en) * 2004-11-22 2004-12-22 Royal College Of Surgeons Ie Treatment of disease
CA2818467A1 (en) * 2009-11-18 2011-05-26 Murray Goulburn Co-Operative Co. Limited Recombinant microorganisms

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229531A (en) * 1978-12-29 1980-10-21 Monsanto Company Production of tumor angiogenesis factor by cell culture
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
US4529590A (en) * 1982-12-27 1985-07-16 Leveen Robert F Production of angiogenetic factor
US4503038A (en) * 1983-02-25 1985-03-05 The Regents Of The University Of California Extracellular nonmitogenic angiogenesis factor and method of isolation thereof from wound fluid
US4721672A (en) * 1985-08-28 1988-01-26 President And Fellows Of Harvard College CDNA and gene for human angiogenin (angiogenesis factor) and methods of expression

Also Published As

Publication number Publication date
DK215287D0 (da) 1987-04-28
EP0235162A4 (de) 1987-11-12
DK215287A (da) 1987-04-28
ATE71632T1 (de) 1992-02-15
JPH0755156B2 (ja) 1995-06-14
EP0235162A1 (de) 1987-09-09
US4916073A (en) 1990-04-10
JPS63501052A (ja) 1988-04-21
JPH0638749B2 (ja) 1994-05-25
WO1987001372A1 (en) 1987-03-12
US4721672A (en) 1988-01-26
CA1316132C (en) 1993-04-13
EP0235162B1 (de) 1992-01-15
JPH0686687A (ja) 1994-03-29

Similar Documents

Publication Publication Date Title
DE3683482D1 (de) Cdns und gen fuer menschliches angiogenin (angiogenesis-faktor) und expression.
DK43890D0 (da) Nucleinsyre, vektorer og celler indeholdende den, derudfra fremstillede produkter og disses anvendelse
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
ATE358176T1 (de) Menschliche dnase
KR880009035A (ko) Apc 폴리펩티드의 전구 단백질, 이를 위한 dna 암호화, 및 이 dna와 단백질의 진단 용도
DE68919229D1 (de) Hybride prokoagulierende proteine.
NZ215867A (en) Aids envelope protein, dna vectors and method of production
NO177678C (no) Fremgangsmåte for fremstilling av et terapeutisk aktivt, rekombinant protein som har ASP-aktivitet, ekspresjonssystem samt DNA som koder for nevnte protein
PH25120A (en) Replicable expression vehicle and process of preparation thereof
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
ATE168135T1 (de) Diagnose von retinoblastoma
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
ES2052583T3 (es) Derivados de peptidos relacionados con el gel calcitonina.
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
PT83939A (en) Method for the production of human placenta angiogenic factor capable of stimulating capillary endothelial cell protease synthesis dna synthesis and migration
NO169819C (no) Fremgangsmaate for fremstilling av hybrid polypeptid og dna-molekyl for bruk i denne
ATE300554T1 (de) Bindegewebe-wachstumsfaktor 3.
DK383488A (da) Humant papillomavirus type 41, dets dna og deraf kodede proteiner
ZA868813B (en) Dna sequence,recombinant dna and process for producing human tissue plasminogen activator
NO900745L (no) Humant mannose-bindende protein.
NO863976D0 (no) Cystein-beroevede muteiner av biologisk aktive human tumornekrosefaktorproteiner.
IT8349430A0 (it) Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici

Legal Events

Date Code Title Description
8364 No opposition during term of opposition